2017
Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom
Alasil T, Munoz N, Keane PA, Tufail A, Coady PA, Novais E, de Carlo TE, Baumal CR, Waheed NK, Duker JS, Adelman RA. Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom. International Journal Of Retina And Vitreous 2017, 3: 9. PMID: 28428893, PMCID: PMC5392942, DOI: 10.1186/s40942-017-0060-4.Peer-Reviewed Original ResearchPolypoidal choroidal vasculopathyFinal visual acuityWorse visual outcomeVisual acuityBilateral diseaseVisual outcomeTertiary centerFemale predominanceChoroidal vasculopathyDiagnosis of PCVInitial visual acuityRacial variationMulticenter retrospective studyLength of followDifferent treatment modalitiesSignificant decreaseIndocyanine green angiography imagesLens statusPCV patientsVision gainInitial presentationRetrospective studyWorse visionPolypoidal lesionsTreatment modalities
2015
Strategy for the Management of Diabetic Macular Edema: The European Vitreo‐Retinal Society Macular Edema Study
Adelman R, Parnes A, Michalewska Z, Parolini B, Boscher C, Ducournau D. Strategy for the Management of Diabetic Macular Edema: The European Vitreo‐Retinal Society Macular Edema Study. BioMed Research International 2015, 2015: 352487. PMID: 25695062, PMCID: PMC4324105, DOI: 10.1155/2015/352487.Peer-Reviewed Original ResearchConceptsDiabetic macular edemaMacular edemaVisual acuityVisual improvementBetter visual improvementMulticenter clinical studyPars plana vitrectomySignificant visual improvementEdema studyTriamcinolone monotherapyVEGF therapyVEGF injectionVision gainClinical findingsGrid laserPlana vitrectomyRetina specialistsClinical studiesDifferent therapiesClinical informationEdemaAcuityTherapyMean numberTreatment